Latest
Stock Titan Market update
AN2 Therapeutics (ANTX) director reports gift of 405,880 shares and 145,538 held
AN2 Therapeutics director Joseph S. Zakrzewski reported a bona fide gift of 405,880 shares of common stock, which were previously held indirectly through the Z3 Trust. He disavows beneficial ownership of these gifted shares. Following this transaction, Zakrzewski directly holds 145,538 shares of AN2 Therapeutics common stock.
Main company
🇺🇸 United States
Read at Stock Titan